Conference
External validation of nomogram to predict progression-free survival at 6 months (PFS6) in patients receiving salvage therapy for advanced urothelial carcinoma (UC).
Authors
Sonpavde G; Bellmunt J; Fougeray R; Salhi Y; Pond GR
Volume
32
Pagination
pp. 4542-4542
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.4542
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X